Publicaciones en colaboración con investigadores/as de Universidad Alfonso X el Sabio (20)

2024

  1. COVID-19: On the threshold of the fifth year. The situation in Spain

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 17-28

  2. Respiratory syncytial virus: A new era

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 134-148

2023

  1. Advantages and disadvantages of maintaining the mandatory use of masks in health centers and nursing homes in Spain. How and when is it justified to maintain it?

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 466-469

  2. Tuberculosis in Spain: An opinion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 6, pp. 562-583

2022

  1. Actions and attitudes on the immunized patients against SARS-CoV-2

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 7-15

  2. COVID in Pediatric Age: an opinion paper

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 333-343

  3. COVID-19: Some unresolved issues

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 421-434

  4. Lessons from COVID-19 for future disasters: an opinion paper

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 444-454

  5. Low levels of influenza vaccine uptake among the diabetic population in Spain: A time trend study from 2011 to 2020

    Journal of Clinical Medicine, Vol. 11, Núm. 1

  6. Monkeypox in humans: a new outbreak

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 6, pp. 509-518

  7. Persistence and viability of SARS-CoV-2 in primary infection and reinfections

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 1-6

  8. Time Trends (2012–2020), Sex Differences and Predictors for Influenza Vaccination Uptake among Individuals with Chronic Obstructive Pulmonary Disease in Spain

    Journal of Clinical Medicine, Vol. 11, Núm. 5

2021

  1. Assessing the usefulness of the prevexair smartphone application in the follow-up high-risk patients with COPD

    International Journal of COPD, Vol. 16, pp. 53-65

  2. New variants of SARS-CoV-2

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 5, pp. 419-428

  3. Post-covid syndrome: A reflection and opinion paper

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 4, pp. 269-279

2020

  1. Cross-speciality geriatrics: A health-care challenge for the 21st century

    Revista Espanola de Geriatria y Gerontologia, Vol. 55, Núm. 2, pp. 84-97

2019

  1. Comparison of different strategies for short-term death prediction in the infected older patient

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 156-164

2018

  1. 180-day risk of mortality in older patients admitted to short-stay units: The 6-month short-stay unit (6M UCE) Score

    Emergencias, Vol. 30, Núm. 5, pp. 315-320

  2. Multidimensional intervention to improve the short-term prognosis of frail elderly patients discharged from a short-stay unit: A quasiexperimental study

    Revista Clinica Espanola, Vol. 218, Núm. 4, pp. 163-169

2017

  1. FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms

    British Journal of Clinical Pharmacology, Vol. 83, Núm. 12, pp. 2661-2670